$ETST In particular, the new products would be focused on breast cancer, improvement in human brain cell function and improvements in immune cell functions. It should be noted here that the company has already conducted an in vitro study, which proves the effectiveness of CBD for the stated conditions. Moreover, ETST also has a provisional patent application pending, with regards to this study. The CEO and CSO of Earth Science, Dr. Michel Aube, claimed that the drugs would treat a number of diseases, which include depression, anxiety, fatty liver disease and triple-negative breast cancer. He further voiced his belief that this represents a large market for the products and he was looking forward to discuss further details of the project.
https://www.journaltranscript.com/2016/12/ear...-products/